$SCYX
SCYNEXIS INC

2023 Q1 Form 10-K Financial Statement

#000095017023011138 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $1.100M $1.524M $5.091M
YoY Change 60.12% 155.28% -61.32%
Cost Of Revenue $137.0K $196.0K $628.0K
YoY Change 38.38% 17.37% 101.28%
Gross Profit $993.0K $1.328M $4.463M
YoY Change 68.88% 208.84% -65.27%
Gross Profit Margin 90.27% 87.14% 87.66%
Selling, General & Admin $4.840M $15.96M $62.96M
YoY Change -66.83% 6.14% 26.13%
% of Gross Profit 487.41% 1201.81% 1410.73%
Research & Development $6.835M $7.849M $27.26M
YoY Change 19.18% 2.07% 14.66%
% of Gross Profit 688.32% 591.04% 610.78%
Depreciation & Amortization $151.0K $155.0K $606.0K
YoY Change -2.58% -36.99% 203.0%
% of Gross Profit 15.21% 11.67% 13.58%
Operating Expenses $11.81M $23.81M $90.85M
YoY Change -41.89% 4.76% 22.77%
Operating Profit -$10.68M -$22.48M -$85.76M
YoY Change -45.88% 0.83% 40.96%
Interest Expense $1.447M $8.049M $5.198M
YoY Change -84.89% -215.66% -81.16%
% of Operating Profit
Other Income/Expense, Net -$23.19M $3.000K $18.25M
YoY Change -341.93% -76.92% -26.67%
Pretax Income -$33.88M -$14.43M -$67.50M
YoY Change 233.72% -50.66% 87.5%
Income Tax $0.00 $0.00 -$4.700M
% Of Pretax Income
Net Earnings -$33.88M -$14.43M -$62.80M
YoY Change 521.46% -50.66% 91.08%
Net Earnings / Revenue -3079.64% -946.78% -1233.55%
Basic Earnings Per Share -$0.71 -$1.47
Diluted Earnings Per Share -$0.71 -$0.30 -$1.47
COMMON SHARES
Basic Shares Outstanding 33.32M 32.66M 42.61M
Diluted Shares Outstanding 47.76M 42.61M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.82M $73.50M $73.50M
YoY Change -42.42% -29.65% -29.65%
Cash & Equivalents $26.91M $45.81M $45.81M
Short-Term Investments $27.91M $27.69M $27.69M
Other Short-Term Assets $291.0K $62.00K $2.558M
YoY Change 7175.0% 1450.0% -28.33%
Inventory $1.105M $899.0K $899.0K
Prepaid Expenses
Receivables $2.060M $2.101M $2.101M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $59.77M $79.06M $79.06M
YoY Change -41.35% -27.72% -27.72%
LONG-TERM ASSETS
Property, Plant & Equipment $2.540M $2.594M $2.594M
YoY Change -9.61% 2195.58% -10.98%
Goodwill
YoY Change
Intangibles $309.0K $408.0K
YoY Change -61.36%
Long-Term Investments
YoY Change
Other Assets $7.444M $5.511M $5.747M
YoY Change 26.49% -11.61% -11.45%
Total Long-Term Assets $10.53M $8.749M $8.749M
YoY Change 9.04% -16.36% -16.36%
TOTAL ASSETS
Total Short-Term Assets $59.77M $79.06M $79.06M
Total Long-Term Assets $10.53M $8.749M $8.749M
Total Assets $70.30M $87.81M $87.81M
YoY Change -36.99% -26.73% -26.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.925M $5.937M $5.937M
YoY Change -27.12% -24.35% -24.35%
Accrued Expenses $4.775M $5.628M $5.910M
YoY Change 5.57% -1.23% 2.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $34.65M
YoY Change
Total Short-Term Liabilities $45.64M $17.62M $17.62M
YoY Change 252.63% 29.39% 29.39%
LONG-TERM LIABILITIES
Long-Term Debt $11.41M $45.39M $45.39M
YoY Change -74.38% 12.5% 12.5%
Other Long-Term Liabilities $43.16M $0.00 $21.57M
YoY Change 952.15% -100.0% -12.38%
Total Long-Term Liabilities $54.57M $0.00 $66.96M
YoY Change 1230.23% -100.0% 3.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.64M $17.62M $17.62M
Total Long-Term Liabilities $54.57M $0.00 $66.96M
Total Liabilities $100.2M $84.58M $84.58M
YoY Change 37.96% 7.63% 7.63%
SHAREHOLDERS EQUITY
Retained Earnings -$456.2M -$422.3M
YoY Change 25.02% 17.48%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$29.91M $3.233M $3.233M
YoY Change
Total Liabilities & Shareholders Equity $70.30M $87.81M $87.81M
YoY Change -36.99% -26.73% -26.73%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$33.88M -$14.43M -$62.80M
YoY Change 521.46% -50.66% 91.08%
Depreciation, Depletion And Amortization $151.0K $155.0K $606.0K
YoY Change -2.58% -36.99% 203.0%
Cash From Operating Activities -$18.92M -$22.81M -$79.88M
YoY Change 18.36% -10.63% 46.41%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $9.000K
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$27.38M
YoY Change
Cash From Investing Activities $0.00 $0.00 -$27.39M
YoY Change -100.0% -100.0% 2236.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $47.25M
YoY Change 22.56%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 22.00K 0.000 48.60M
YoY Change -99.67% -100.0% -27.59%
NET CHANGE
Cash From Operating Activities -18.92M -22.81M -79.88M
Cash From Investing Activities 0.000 0.000 -27.39M
Cash From Financing Activities 22.00K 0.000 48.60M
Net Change In Cash -18.90M -22.81M -58.67M
YoY Change -381.52% -621.28% -615.19%
FREE CASH FLOW
Cash From Operating Activities -$18.92M -$22.81M -$79.88M
Capital Expenditures $0.00 $0.00 $9.000K
Free Cash Flow -$18.92M -$22.81M -$79.89M
YoY Change 18.42% -8.55% 46.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001178253
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-36365
CY2022 dei Entity Registrant Name
EntityRegistrantName
SCYNEXIS, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2181648
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
1 Evertrust Plaza
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
13th Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Jersey City
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07302 - 6548
CY2022 dei City Area Code
CityAreaCode
201
CY2022 dei Local Phone Number
LocalPhoneNumber
884-5485
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022 dei Trading Symbol
TradingSymbol
SCYX
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
60150447
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33324131
CY2022 dei Auditor Firm
AuditorFirmId
34
CY2022 dei Auditor Name
AuditorName
DELOITTE & TOUCHE LLP
CY2022 dei Auditor Location
AuditorLocation
Morristown, New Jersey
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45814000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104484000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
27689000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2503000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3569000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2101000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
861000
CY2022Q4 us-gaap Inventory Net
InventoryNet
899000
CY2021Q4 us-gaap Inventory Net
InventoryNet
463000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
55000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2022Q4 us-gaap Assets Current
AssetsCurrent
79061000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
109377000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5511000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6235000
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
73000
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
150000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
163000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
218000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
408000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1056000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
425485000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
400705000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-422288000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-359479000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3233000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2594000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2801000
CY2022Q4 us-gaap Assets
Assets
87810000
CY2021Q4 us-gaap Assets
Assets
119837000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5937000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7848000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5628000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5698000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5771000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
282000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17618000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13616000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3345000
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
18644000
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
18062000
CY2022Q4 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
11001000
CY2021Q4 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
11607000
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
34393000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
28745000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2921000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3204000
CY2022Q4 us-gaap Liabilities
Liabilities
84577000
CY2021Q4 us-gaap Liabilities
Liabilities
78579000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32682342
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32682342
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28705334
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28705334
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
36000
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
32000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41258000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87810000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
119837000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5091000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13163000
CY2022 scyx Cost Of Product Revenues
CostOfProductRevenues
628000
CY2021 scyx Cost Of Product Revenues
CostOfProductRevenues
312000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27259000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23773000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62961000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49916000
CY2022 us-gaap Operating Expenses
OperatingExpenses
90848000
CY2021 us-gaap Operating Expenses
OperatingExpenses
74001000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-85757000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-60838000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1589000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1303000
CY2022 us-gaap Interest Income Other
InterestIncomeOther
1415000
CY2021 us-gaap Interest Income Other
InterestIncomeOther
24000
CY2022 us-gaap Interest Expense
InterestExpense
5198000
CY2021 us-gaap Interest Expense
InterestExpense
2660000
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3000
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
13000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-22301000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-30365000
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1316000
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1170000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18248000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
24884000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-67509000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35954000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4700000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3088000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-62809000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-32866000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.47
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.47
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.25
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.25
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42613510
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42613510
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26384713
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26384713
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22758000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-32866000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2088000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
22000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
41040000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
7453000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
3000
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
766000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41258000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-62809000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3685000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
18000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21010000
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
71000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3233000
CY2022 us-gaap Profit Loss
ProfitLoss
-62809000
CY2021 us-gaap Profit Loss
ProfitLoss
-32866000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
606000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
379000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3686000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2088000
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
309000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1589000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1303000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-22301000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-30365000
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1316000
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1170000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
207000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
198000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1636000
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1597000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1240000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
861000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
436000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5292000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1481000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2763000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2285000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4941000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79883000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54560000
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1172000
CY2022 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
27380000
CY2021 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27389000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1172000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47248000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38552000
CY2022 scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
3638000
CY2021 scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
205000
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5000000
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
30000000
CY2022 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
26000
CY2021 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
1253000
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
18000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
22000
CY2022 scyx Payments For Proceeds From Repurchase Of Shares To Satisfy Tax Withholdings
PaymentsForProceedsFromRepurchaseOfSharesToSatisfyTaxWithholdings
0
CY2021 scyx Payments For Proceeds From Repurchase Of Shares To Satisfy Tax Withholdings
PaymentsForProceedsFromRepurchaseOfSharesToSatisfyTaxWithholdings
-4000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48602000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
67120000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-58670000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
11388000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104702000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93314000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46032000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104702000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5190000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2255000
CY2022 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
1106000
CY2021 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
24000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
78000
CY2022 scyx Deferred Offering And Issuance Costs Included In Accounts Payable
DeferredOfferingAndIssuanceCostsIncludedInAccountsPayable
0
CY2021 scyx Deferred Offering And Issuance Costs Included In Accounts Payable
DeferredOfferingAndIssuanceCostsIncludedInAccountsPayable
430000
CY2022 scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
77000
CY2021 scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
86000
CY2022 us-gaap Stock Issued1
StockIssued1
0
CY2021 us-gaap Stock Issued1
StockIssued1
7452000
CY2022 scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
71000
CY2021 scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
298000
CY2022 scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
206000
CY2021 scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
390000
CY2022 scyx Settlement Of Liability For Exercise Of Warrants
SettlementOfLiabilityForExerciseOfWarrants
0
CY2021 scyx Settlement Of Liability For Exercise Of Warrants
SettlementOfLiabilityForExerciseOfWarrants
3091000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-62800000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-32900000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-422300000
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
73500000
CY2022 scyx Debt Instrument Minimum Outstanding Term Loan Principal Percentage For Financial Covenant Waived
DebtInstrumentMinimumOutstandingTermLoanPrincipalPercentageForFinancialCovenantWaived
0.50
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments, which potentially expose the Company to concentrations of credit risk, consist principally of cash on deposit, cash equivalents, short-term investments, and accounts receivable. The Company's money market fund investment (recognized as cash and cash equivalents) and short-term investments are with what the Company believes to be high quality issuers. The Company has not experienced any significant losses in such accounts. See Note 11 for concentrations of credit risk associated with the Company’s accounts receivable and revenue with customers.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company held cash, cash equivalents, and short-term investments at Silicon Valley Bank (“SVB”). On March 10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, and the Federal Deposit Insurance Corporation (“FDIC”) was appointed as receiver. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of the closure of SVB on March 10, 2023, the Company held approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in cash on deposit and approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in a money market account with SVB who was administering the account as our agent. The Company's remaining cash, cash equivalents and short-term investments are primarily held in a money market account and in U.S. treasury securities that are unaffiliated with SVB and held with another financial institution acting as custodian, but which SVB administers on the Company's behalf. The Company is able to access all cash, cash equivalents and short-term investments held at or through SVB and at our financial institution custodians. The Company has not experienced any losses in such accounts.</span></p>
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46000000.0
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104700000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26359399
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10633380
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassification of Prior Year Amounts</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior year amounts have been reclassified for consistency with the current year presentation.</span></p>
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
27689000
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
160000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
27529000
CY2022Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
635000
CY2021Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
247000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
622000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
505000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1184000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2813000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
62000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2503000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3569000
CY2021Q4 scyx Debt Instrument Final Fee Due At Maturity
DebtInstrumentFinalFeeDueAtMaturity
1383000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5093000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5162000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
610000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
24000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
127000
CY2022Q4 scyx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
5727000
CY2021Q4 scyx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
5292000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1282000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1250000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
874000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
194000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
408000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1056000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
CY2022 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
400000
CY2022Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
786000
CY2021Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
1498000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1628000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2012000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1313000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1078000
CY2022Q4 scyx Accrued Severance
AccruedSeverance
688000
CY2022Q4 scyx Accrued Rebates Current
AccruedRebatesCurrent
595000
CY2021Q4 scyx Accrued Rebates Current
AccruedRebatesCurrent
836000
CY2022Q4 scyx Accrued Other Rebates
AccruedOtherRebates
618000
CY2021Q4 scyx Accrued Other Rebates
AccruedOtherRebates
274000000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5628000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5698000
CY2021Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
20000000.0
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
500000
CY2021Q2 scyx Fair Value Of Initial Warrant Liabilities Recorded As Deferred Asset And Reclassified To Debt Discount
FairValueOfInitialWarrantLiabilitiesRecordedAsDeferredAssetAndReclassifiedToDebtDiscount
700000
CY2022 us-gaap Debt Instrument Description
DebtInstrumentDescription
Upon the funding of the $10.0 million and $5.0 million for the second and third tranches in June 2021 and March 2022, the associated warrant liabilities of $0.3 million and $0.1 million were reclassed to additional paid in capital at settlement and 56,803 and 28,401 of warrants to purchase shares of the Company's common stock vested, respectively.
CY2021Q2 scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
300000
CY2022Q1 scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
100000
CY2021Q2 scyx Warrants To Purchase Shares Common Stock Vested
WarrantsToPurchaseSharesCommonStockVested
56803
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
23562000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
11438000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
35000000
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
36383000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1990000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
34393000
CY2022Q4 scyx Termination Fee
TerminationFee
1500000
CY2022 us-gaap Severance Costs1
SeveranceCosts1
1300000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
CY2018Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has the option to renew for two consecutive five-year periods from the end of the first term and the Company is not reasonably certain that the option to renew the Lease will be exercised. Under the Lease, the Company furnished a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which will be reduced by fifty-five thousand dollars every two years for ten years after the commencement of the lease
CY2018Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
664000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
664000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
49000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
38000
CY2022 us-gaap Lease Cost
LeaseCost
713000
CY2021 us-gaap Lease Cost
LeaseCost
702000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
527000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
517000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M2D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M2D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
715000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
730000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
744000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
759000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
774000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1256000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4978000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1541000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4700000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3100000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-67500000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36000000.0
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3203000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
282000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2921000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3203000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1775000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32682342
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32682342
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28705334
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28705334
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
42489050
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14367493
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1775150
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-22300000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-30400000
CY2022Q4 scyx Fair Value Of Liabilities
FairValueOfLiabilities
18600000
CY2021 scyx Contract With Customer Liability Provision Related To Current Period Revenue
ContractWithCustomerLiabilityProvisionRelatedToCurrentPeriodRevenue
3106000
CY2022 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
0
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1726000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1380000
CY2022 scyx Contract With Customer Liability Provision Related To Current Period Revenue
ContractWithCustomerLiabilityProvisionRelatedToCurrentPeriodRevenue
5461000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5300000
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
-4700000
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
-4188000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1100000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-4700000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-3088000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-13176000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7781000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-319000
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.005
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1144000
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.031
CY2022 scyx Income Tax Reconciliation State Effect Of Permanent Items
IncomeTaxReconciliationStateEffectOfPermanentItems
-114000
CY2022 scyx Effective Income Tax Rate Reconciliation State Effect Of Permanent Items
EffectiveIncomeTaxRateReconciliationStateEffectOfPermanentItems
0.002
CY2021 scyx Income Tax Reconciliation State Effect Of Permanent Items
IncomeTaxReconciliationStateEffectOfPermanentItems
-906000
CY2021 scyx Effective Income Tax Rate Reconciliation State Effect Of Permanent Items
EffectiveIncomeTaxRateReconciliationStateEffectOfPermanentItems
0.024
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1100000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.030
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
123000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.002
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
114000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.003
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
379000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.006
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
339000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.009
CY2022 scyx Effective Income Tax Rate Reconciliation Issuance Of Warrants
EffectiveIncomeTaxRateReconciliationIssuanceOfWarrants
-4960000
CY2022 scyx Effective Income Tax Rate Reconciliation Issuance Of Warrants Percent
EffectiveIncomeTaxRateReconciliationIssuanceOfWarrantsPercent
0.079
CY2021 scyx Effective Income Tax Rate Reconciliation Issuance Of Warrants
EffectiveIncomeTaxRateReconciliationIssuanceOfWarrants
-6622000
CY2021 scyx Effective Income Tax Rate Reconciliation Issuance Of Warrants Percent
EffectiveIncomeTaxRateReconciliationIssuanceOfWarrantsPercent
0.179
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
713000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.012
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-489000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.013
CY2022 scyx Income Tax Reconciliation Net Operating Loss Sale
IncomeTaxReconciliationNetOperatingLossSale
237000
CY2022 scyx Effective Income Tax Rate Reconciliation Net Operating Loss Sale
EffectiveIncomeTaxRateReconciliationNetOperatingLossSale
-0.004
CY2021 scyx Income Tax Reconciliation Net Operating Loss Sale
IncomeTaxReconciliationNetOperatingLossSale
214000
CY2021 scyx Effective Income Tax Rate Reconciliation Net Operating Loss Sale
EffectiveIncomeTaxRateReconciliationNetOperatingLossSale
-0.006
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
12417000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.198
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
12087000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.326
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4700000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.074
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3088000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.083
CY2022Q4 scyx Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Expenses Noncurrent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedExpensesNoncurrent
578000
CY2021Q4 scyx Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Expenses Noncurrent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedExpensesNoncurrent
1264000
CY2022Q4 scyx Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Noncurrent
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostNoncurrent
2675000
CY2021Q4 scyx Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Noncurrent
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostNoncurrent
2554000
CY2022Q4 scyx Deferred Tax Assets Tax Deferred Expense Lease Liability
DeferredTaxAssetsTaxDeferredExpenseLeaseLiability
689000
CY2021Q4 scyx Deferred Tax Assets Tax Deferred Expense Lease Liability
DeferredTaxAssetsTaxDeferredExpenseLeaseLiability
789000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4398000
CY2021Q4 scyx Deferred Tax Liabilities Other Noncurrent
DeferredTaxLiabilitiesOtherNoncurrent
757000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
88363000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
80453000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6839000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6839000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
103542000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
91142000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
103542000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
91142000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 scyx Tax Cuts And Job Acts Of2017 Temporary Expense For Certain Business Assets And Property Percentage
TaxCutsAndJobActsOf2017TemporaryExpenseForCertainBusinessAssetsAndPropertyPercentage
1
CY2022 scyx Tax Cuts And Jobs Act Of2017 Maximum Percentage Of Pre Net Operating Loss Deduction Taxable Income Limit For Net Operating Loss Deduction
TaxCutsAndJobsActOf2017MaximumPercentageOfPreNetOperatingLossDeductionTaxableIncomeLimitForNetOperatingLossDeduction
0.80
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
436000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
436000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2022 scyx Unrecognized Tax Benefits Decreases Resulting From Deferred Rate Change
UnrecognizedTaxBenefitsDecreasesResultingFromDeferredRateChange
0
CY2021 scyx Unrecognized Tax Benefits Decreases Resulting From Deferred Rate Change
UnrecognizedTaxBenefitsDecreasesResultingFromDeferredRateChange
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
436000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
436000
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2022Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.47
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.63
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
2100000
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
4000000.0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1542126
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.89
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M12D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
834000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.76
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
635818
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.62
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1740308
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.21
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M28D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1188912
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
15.85
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y9M29D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1740308
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
12.21
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y1M28D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1600000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1600000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1500000
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3500000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2100000
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3512000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2088000
CY2022 scyx Defined Contribution Plan Required Work Hours Per Week
DefinedContributionPlanRequiredWorkHoursPerWeek
20
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2022 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2022 scyx Defined Contribution Plan Employers Matching Contribution Vesting Period
DefinedContributionPlanEmployersMatchingContributionVestingPeriod
P4Y
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000

Files In Submission

Name View Source Status
0000950170-23-011138-index-headers.html Edgar Link pending
0000950170-23-011138-index.html Edgar Link pending
0000950170-23-011138.txt Edgar Link pending
0000950170-23-011138-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img241939675_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-20221231.htm Edgar Link pending
scyx-20221231.xsd Edgar Link pending
scyx-ex10_38.htm Edgar Link pending
scyx-ex10_39.htm Edgar Link pending
scyx-ex10_40.htm Edgar Link pending
scyx-ex23_1.htm Edgar Link pending
scyx-ex31_1.htm Edgar Link pending
scyx-ex31_2.htm Edgar Link pending
scyx-ex32_1.htm Edgar Link pending
Show.js Edgar Link pending
scyx-20221231_cal.xml Edgar Link unprocessable
scyx-20221231_def.xml Edgar Link unprocessable
scyx-20221231_lab.xml Edgar Link unprocessable
scyx-20221231_pre.xml Edgar Link unprocessable
scyx-20221231_htm.xml Edgar Link completed